A Simple Blood Test Could Transform Parkinson’s Research 🧠

Scientists are making progress toward blood-based biomarkers that could improve Parkinson’s disease research. A key focus is alpha-synuclein, a protein that forms harmful clumps in the brains of people with Parkinson’s. Researchers are studying both total alpha-synuclein and its disease-linked form, pS129-alpha-synuclein, which may better reflect disease activity. Unlike spinal fluid tests, blood tests are less invasive and could allow easier monitoring over time, helping researchers track disease progression and evaluate new therapies. While technical challenges remain, advances in ultra-sensitive detection methods are bringing researchers closer to reliable, scalable biomarkers that could accelerate future Parkinson’s diagnosis and treatment research.
Read more at NewsMedical